Eleva is separating its moss-based biologics platform from its clinical-stage [...]

L-glutamine combined with chemotherapy produced a 44% response rate in [...]

Lumen Bioscience has received up to $7m in US government [...]

The FDA has granted Fast Track designation to Erasca’s investigational [...]

The first UK patient has been dosed with a personalised [...]

Verdiva Bio has dosed the first patient in a Phase [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Mission Therapeutics has signed a deal worth up to US$292 [...]

Kairos Pharma has reported positive interim safety results from an [...]

Rani Therapeutics has reported positive initial Phase 1a data for [...]